APPA6716

SSTR1 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 APPA6716-Each-of-1 In Stock ₹ 46,502.50

APPA6716 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

SSTR1

Classification

Polyclonal

Conjugate

Unconjugated

Gene

SSTR1

Gene Alias

Gpcrrna; RNGPCRRNA; Smstr1; Smstr-1; somatostatin receptor; somatostatin receptor 1; Somatostatin receptor subtype 1; somatostatin receptor type 1; SRIF-2; SS1R; SS-1-R; SS1-R; sst1; Sst1 receptor; Sstr1

Host Species

Rabbit

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Applications

Immunoprecipitation, Western Blot

Concentration

Conc. Not Determined

Formulation

whole serum with 0.05% sodium azide

Gene Accession No.

P28646, P30872, P30873

Gene Symbols

SSTR1

Immunogen

Synthetic peptide corresponding to the C-terminus of rat SSR1 receptor.

Regulatory Status

RUO

Gene ID (Entrez)

20605, 25033, 6751

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Thermo Scientific

FEMA551211

--

Img

Thermo Scientific

FEMA549799

--

Img

Thermo Scientific

APS301

--

Img

Thermo Scientific

FEMA550074

--

Img

Thermo Scientific

APPA6713

--

Img

Thermo Scientific

APPA6715

--

Img

Thermo Scientific

APS300

--

Img

Thermo Scientific

APPH36

--

Description

  • This antibody is not recommended for ICC/IF applications
  • Somatostatin acts to regulate numerous physiological processes by binding to and activating specific receptors in target tissues
  • Activation of these receptors by somatostatin, which is secreted by nerve and endocrine cells, regulates the secretion of insulin, glucagon and growth hormone, neuronal excitability in both the brain and the peripheral nervous system, and cell growth
  • Somatostatin receptors have been implicated in numerous diseases ranging from Alzheimer's to cancers of the gastrointestinal tract, breast, prostate, and pituitary.